ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.

Wilens T, Pelham W, Stein M, Conners CK, Abikoff H, Atkins M, August G, Greenhill L, McBurnett K, Palumbo D, Swanson J, Wolraich M. ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):424-33.

View in: PubMed

subject areas

Adolescent
Attention Deficit Disorder with Hyperactivity
Central Nervous System Stimulants
Child
Drug Administration Schedule
Female
Follow-Up Studies
Humans
Male
Methylphenidate

authors with profiles

William Pelham

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support